A leading Contract Research and Development Organization (CRDO) – Arcinova has invested in a Uniqsis FlowSyn™ continuous flow reactor enabling them to develop and simplify the scale-up of a ...
U.S. API maker Wilmington PharmaTech plans to spend $50 million to double the current API reactor capacity at its Delaware facility. (Stock photo/Getty Images) Wilmington PharmaTech, a CRDMO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results